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Intrarenal distribution of clusterin following reduction of renal mass.
Clusterin is a multifunctional protein isolated from a number of tissues
in several different species. In a variety of renal diseases, clusterin
appears in the glomerulus and tubules in association with the membrane
attack complex of complement. It is also transiently expressed after
several forms of acute renal injury. In this study, we examined the
expression and intrarenal distribution of clusterin following subtotal
renal ablation. Male rats were subjected to either 1-1/3 nephrectomy
(1-1/3 NX), uninephrectomy (UNX) or sham operation (SHAM). Two
weeks after surgery, clusterin mRNA was elevated in the 1-1/3 NX
group (1-1/3 NX: 1215 88; UNX: 208 11; SHAM: 207 19 OD
units; P < 0.001). Clusterin mRNA increased between 3 and 24 hours
after 1-1/3 NX, plateaued, and remained elevated for at least seven
weeks. The increased clusterin mRNA in 1-1/3 NX was localized to the
tissue adjacent to the infarctive scar (scar 858 173 vs. non-scar 98
27 OD units; P < 0.001). Clusterin protein followed a similar pattern of
localization, being increased in most tubules and some peritubular
capillaries in the pen-infarct zone. Only occasional tubules were
positive for clusterjn in the renal tissue distant from the scar or in the
kidneys of sham operated rats. Co-localization of clusterin and C5b-9
was not detected. Evidence for apoptosis was found in the pen-infarct
zone but not elsewhere in 1-1/3 NX kidney or in the normal kidney
following sham operation. Infarction of 1/3 of the left kidney without
contralateral nephrectomy, a maneuver which eliminates the compen-
satory growth, and uremia seen with 1-1/3 NX still resulted in increased
clustenin mRNA in the infarcted left kidney compared to the intact right
kidney (LK: 790 112 vs. RK: 128 25 OD units; P <0.001), although
the amount of clusterin mRNA was less than that found following 1-1/3
NX. In conclusion, persistently increased clustenn mRNA and protein
was seen in the pen-infarct zone following 1-1/3 NX. This increased
expression of clusterin may be playing a role in the ischemia-related
apoptosis present in the scar-adjacent tissue.
Clusterin is a heterodimeric glycoprotein of molecular weight
of 80 kDa which has been isolated and cloned from a variety of
tissues in several different species [l.—17]. Consequently, sev-
eral names have been applied, including testosterone repressed
prostate message-2 (TRPM-2) [4, 61, sulfated glycoprotein-2
(SGP-2) [5, 8, 10], dimeric acidic glycoprotein (DAG) [3],
SP-40,40 [7, 9, 12, 151, complement cytolysis inhibitor (CLI)
[111, gp 80 [16], apolipoprotein J [18, 19], NA 1/NA 2 [171, and
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glycoprotein III [131. Hereafter we will refer to this protein as
clusterin [12].
A variety of biological functions have been associated with
clusterin. These include cell regression and apoptosis (also
known as programmed cell death) [4, 6, 20—22], cell adhesion
and/or aggregation [1, 2, 12], adrenal medullary secretion [131,
reproduction [9, 12], lipid transport [17—19, 23], and regulation
of the cytolytic activity of the membrane attack complex of
complement C5b-9 (MAC) [7,9, 11,24]. In the kidney, clusterin
appeared as a component of the glomerular immune deposits in
immune complex glomerulonephritis, where it was found in a
pattern of distribution similar to that of the terminal comple-
ment components [7, 25, 26]. As well, clusterin mRNA has been
examined in several rat models of non-immunologic acute renal
injury. Increased clusterin mRNA occurred transiently follow-
ing ureteric obstruction [22, 27], ischemia/reperfusion [28, 29],
and nephrotoxic injury [301, and more prolonged increased
clusterin mRNA was seen in the epithelial cells lining the cysts
in a genetic murine model of polycystic kidney disease [31].
The purpose of this study was to examine the expression and
intrarenal distribution of clusterin in a chronic model of renal
disease. To better characterize the distribution and possible
role of clusterin in chronic renal disease, several models of
renal ablation were explored.
Methods
Models
Subtotal nephrectomy (1-1/3 NX) was performed by removal
of the right kidney and ligation of the posterior branch of the left
renal artery resulting in infarction of approximately 1/3 of the
left kidney.
Uninephrectomy (UNX) consisted of removal of the right
kidney.
Limited infarction (1/3 NX) was accomplished by ligation of
the posterior branch of the left renal artery without removal of
the right kidney.
Sham operation (SHAM) was done by laparotomy without
renal ablation.
All surgery was performed under methohexital anesthesia (5
mg/100 g body wt, intraperitoneally).
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Experimental design
Degree of renal ablation. In the first experiment we examined
the effect of the degree of renal ablation on clusterin mRNA.
Seventeen male Sprague-Dawley rats weighing 250 to 275 g
were subjected to either right uninephrectomy (UNX; N = 5),
right nephrectomy and ligation of the posterior branch of the
left renal artery (1-1/3 NX; N = 6), or sham operation (SHAM;
N = 6). The rats were maintained on a semisynthetic 20%
protein diet (Teklad Diet #170597, Madison, Wisconsin, USA).
Two weeks after the operation, the left kidney was removed,
snap-frozen in liquid nitrogen, and stored at —70°C, for total
RNA extraction.
Time course of expression of clusterin mRNA following 1-1/3
NX. Fifteen male Sprague-Dawley rats weighing 250 to 275 g
underwent either 1-1/3 NX (N = 10) or SHAM operation (N =
5). Rats were maintained on the same dietary regimen as
described in the previous experiment. At different time points
after the surgery (3 hr, 24 hr, 3 days, 14 days, and 48 days), rats
were killed, the left kidney removed, snap-frozen in liquid
nitrogen and stored at —70°C. At each time point two 1-1/3 NX
and one SHAM operated rat were included in the analysis.
Time course of expression of clusterin mRNA following
uninephrectomy. Ten male Sprague-Dawley rats weighing 250
to 275 g underwent UNX. The right kidneys removed during the
surgical procedure were used as controls. At different time
points after the surgery (3 hr, 24 hr, 3 days, 14 days, and 48
days), rats were killed and the left kidneys removed. All the
specimens were snap frozen in liquid nitrogen and stored at
—70°C,
Intrarenal distribution of clusterin and clusterin mRNA in the
remnant kidney. Four male Sprague-Dawley rats weighing 250
to 275 g were subjected to 1-1/3 NX. Two weeks following
surgery, the left kidney was removed and divided longitudinally
into two pieces, one having the scar plus the scar adjacent
tissue (S; posterior half) and the other with the renal tissue
"distant from the scar" or non-scar (N; anterior half; Fig. 1).
The two pieces were snap-frozen in liquid nitrogen and stored at
—70°C. Total RNA was extracted separately in each half.
For light microscopy and clusterin immunoperoxidase stud-
ies, four male Sprague-Dawley rats weighing 250 to 275 g were
subjected to either SHAM operation (N = 2) or 1-1/3 NX (N =
2). Rats were maintained on a 20% protein diet for two weeks,
at which time they were anesthetised with methohexital and the
left kidney was perfusion-fixed with 10% formaldehyde (perfu-
sion pressure of 120 mm Hg). The kidney was harvested,
saggital sections obtained and processed as described below.
For immunofluorescence studies, six male Sprague-Dawley rats
were subjected to either SHAM operation (N = 2) or 1-1/3 NX
(N = 4). Rats were maintained on a similar diet as above for 2
weeks, at which time the left kidney was harvested, saggital
sections obtained and embedded in ornithine carbamyl trans-
ferase compound (OCT; Miles, Elkhart, Indiana, USA) and
snap-frozen for immunofluorescence studies.
Clusterin gene expression following limited infarction.
Eleven male Sprague-Dawley rats weighing 250 to 275 g were
subjected to either ligation of the posterior branch of the left
renal artery (1/3 NX, N = 4), or right nephrectomy and ligation
of the posterior branch of the left renal artery (1-1/3 NX, N
7). Infarction of 1/3 of the left kidney without contralateral
nephrectomy (1/3 NX) is a procedure which maintains local
effects that scarred tissue may exert within the infarcted kidney
but eliminates the compensatory growth and uremia seen fol-
lowing the more extensive 1-1/3 NX. As well, this approach
allowed for the comparison between the left infarcted kidney
and the right intact kidney. After four weeks on a 20% protein
diet, rats were killed and both kidneys from the 1/3 NX group
and the remnant left kidney of the 1-1/3 NX group were
removed, snap-frozen in liquid nitrogen, and stored at —70°C
for total RNA extraction.
To assess glomerular filtration rate and mean arterial pressure
in these models, a parallel experiment was conducted which
included six 1/3 NX and six 1-1/3 NX rats fed the same 20%
protein diet for four weeks. At the end of this period, rats were
anesthetized with mactin (100 mg/kg body weight administered
by intraperitoneal injection; BYK Gulden, Konstanz, Ger-
many) and placed on a temperature regulated table. A PE-50
polyethylene catheter was inserted into the left femoral artery
Anterior Posterior
/I\
Non-scar Scar
Fig 1. This drawing illustrates the division of the left remnant kidney
into two portions, one containing the scar plus the scar-adjacent tissue
(S or posterior half) and the other comprising the renal tissue 'distant
from the scar" (NS or anterior half). Total RNA was extracted
separately in each half.
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for blood sampling and blood pressure monitoring by a pressure
transducer (model P23 Db, Statham Instruments, Oxnard,
California, USA) connected to a duograph recorder (model
ICT-2H Gilson Medical Electronics, Middleton, Wisconsin,
USA). The trachea was catheterized with PE-240 tubing and the
left external jugular vein was catheterized with PE-50 for
infusion. Both ureters in the 1/3 NX and the left ureter in the
1-1/3 NX were catheterized with PE-lO and urine was collected
in preweighed vials. To determine GFR a solution of normal
saline containing methoxy-3H inulin (100 j.Ci/ml) was infused at
a rate of 1.2 ml/hr after a priming dose of 0.5 ml over five
minutes. After allowing 20 minutes for equilibrium, two 20-
minute clearance collections were performed. To replace sur-
gical losses, all rats were infused with isooncotic rat plasma as
follows: 1% of body weight was administered over 20 minutes
and an infusion rate of 0.5 mI/hr was maintained throughout the
study. Radioactivity in the plasma and urine were determined
by liquid scintillation counting.
Gender differences in renal clusterin gene expression in the
remnant kidney. Clusterin mRNA has been cloned from the
regressing rat ventral prostate under the name testosterone
repressed prostate message-2 (TRPM-2) and has been previ-
ously defined as a message with androgen dependence [4, 6, 32].
This experiment was undertaken to explore renal clusterin gene
expression in male versus female rats following both SHAM
operation and 1-1/3 NX. Male and female Sprague-Dawley rats
(weight 250 to 275 g) were subjected to either SHAM operation
(N = 2 of each sex) or 1-1/3 NX (N = 2 of each sex). Four days
after surgery rats were sacrificed, the left kidney was removed
and processed as previously described for total RNA extrac-
tion.
RNA extraction and Northern blot hybridization
Total RNA from the kidney fragments was isolated using a
modification of the guanidinium-isothiocyanate/ce slum chloride
method [33]. The RNA was dissolved in sterile water and RNA
concentrations determined by absorbance readings at 260 nm.
Aliquots (20 tg) of total RNA were separated by electrophore-
sis in a 1% agarose gel containing 20 mtvi MOPS, 1 mivi EDTA,
5 mM sodium acetate pH 7.0, and 2.2 M formaldehyde, and
transferred to nylon membranes (Duralon UVTM, Stratagene,
La Jolla, California, USA). In each gel equivalent loading of
RNA, absence of degradation, and the position of the 28 S and
18 S ribosomal RNA was determined by ethidium bromide
staining. An RNA ladder (BRL, Gaithersburg, Maryland, USA)
was run in some gels to size the hybridized mRNA. RNA was
fixed to the nylon membrane by ultraviolet cross linking
(StratalinkerTM, Stratagene). The membranes were prehybrid-
ized at 60°C for four hours in a buffer containing 5x SSC, 5x
Denhardt's reagent, 50 mrs'i Tris-hydrochioride, pH 7.5, 0.1%
sodium pyrophosphate, 0.2% SDS, 200 g/ml sonicated, dena-
tured salmon testes DNA, and 100 jig/mI yeast tRNA. The
membranes were then hybridized at 42°C with a random oligo-
mer-primer labelled TRPM-2 (clusterin) cDNA probe (see be-
low) for 16 to 18 hours in a buffer containing 50% deionized
formamide, 5x SSC, lx Denhardt's reagent, 50 mi Tris-
hydrochloride, pH 7.5, 0.1% sodium pyrophosphate, 1% SDS,
100 jig/mi salmon testes DNA, and 100 jig/mI yeast tRNA. The
membranes were washed for 45 minutes in 2x SSC and 0.1%
SDS twice at room temperature and once at 60°C, and were
then washed in 0.2x SSC and 0.1% SDS at 60°C for 45 minutes.
Autoradiographs (Kodak XAR-5 film, Eastman Kodak Co.,
Rochester, New York, USA) were obtained and quantified by
computer assisted videodensitometry [34].
Preparation of the cDNA probe
The cDNA probe was rat TRPM-2 (clusterin) (1650 bp; gift of
Martin Tenniswood) [6]. For preparation of the cDNA probe,
We utilized the method of random oligomer-primer labelling
(Promega, Madison, Wisconsin, USA) with 32P-dCTP (6000
Cilmmol; NEN Dupont, Wilmington, Delaware, USA) [35].
The specific activity of the probe was ito 2 x i09 cpm/jig DNA.
Immunohistochemistry
Antibodies. For detection of ciusterin, a rabbit antiserum
(provided by Dr. M. Griswold, Washington State University,
Pullman, Washington, USA) which was originally reported as
anti-rat dimeric acidic glycoprotein (DAG-protein) antibody
was used [5], DAG-protein, initially isolated from primary
cultures of rat Sertoli cells, was later called sulfated glycopro-
tein-2 (SGP-2) and is identical to clusterin. The specificity of
anti-DAG antiserum was demonstrated in the original publica-
tion by immunoprecipitation and Western blot analysis using
supernatants of cultured Sertoli cells. Specific reactivity with
the two polypeptide monomers of DAG was demonstrated [3].
For detection of C5b-9, a murine monoclonal anti-rat C5b-9
antibody (provided by Dr. W. Couser, University of Washing-
ton, Seattle, Washington, USA) was used [361.
Immunoperoxidase studies. Sections from formalin-fixed,
paraffin embedded tissue were deparaffinized in Americlear
(American Scientific Products, Minneapolis, Minnesota, USA)
and rehydrated in absolute ethanol. Endogenous peroxidase
was blocked with 0.8% hydrogen peroxide in absolute metha-
nol. The sections were incubated with 2% sheep serum to block
nonspecific binding and then stained with the peroxidase-
antiperoxidase procedure as previously described [37]. Briefly,
after overnight incubation at 4°C with the primary antibody
(ciusterin rabbit anti-rat polycional antibody) [5] the sections
were incubated with sheep-anti-rabbit antiserum (diluted 1:80)
(Antibodies Inc., Davies, California, USA) and with rabbit
peroxidase-antiperoxidase (diluted 1:300) (Sternberger Meyer
Immunochemicals Inc., Jarrettsviile, Maryland, USA). The
reaction was demonstrated with 3-3' diaminobenzidine tetrahy-
drochioride (0.25 mg/mI) (Sigma Chemical Co., St. Louis,
Missouri, USA) and 0.03% peroxide; the sections were coun-
terstained with Harris hematoxylin. Positive controls were
represented by sections from tissue known to contain the
antigen of interest; negative controls consisted of sections in
which normal rabbit serum was substituted for primary anti-
sera.
Immunofluorescence studies. Ciusterin and the membrane
attack complex C5b-9 were detected as previously described
[261. Whole kidney saggital sections (3 jithick) were cut in a
cryostat, acetone fixed and stained by indirect immunofluores-
cence. For detection of ciusterin, the antibody previously
described was used, followed by fluosercein isothiocyanate
(FITC)-conjugated goat anti-rabbit IgG (Organon Teknika, Cap-
pel Division, West Chester, Pennsylvania, USA). For detection
of C5b-9, the antibody was layered on the tissue, followed by
FITC-conjugated goat anti-mouse IgG F(ab')2 (Tago, Inc.,
—C
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Burlingham, California, USA). The FITC-conjugated antisera
used in the indirect immunofluorescence studies were preab-
sorbed with normal rat plasma and shown to be non-reactive
with control kidney sections.
Statistical analysis
Statistical significance is defined as P <0.05 and the results
are presented as mean standard error of the mean (±sEM).
The significance of the differences was analyzed by either the
Student's t-test of unpaired data or one way ANOVA when
three group comparisons were made. Student-Newman-Keuls
test was used for intergroup comparisons [38].
Results
Degree of renal ablation
The mean body weights of the SHAM, UNX and 1-1/3 NX
groups were similar at the beginning of the study (SHAM: 263
6 vs. UNX: 269 I vs. 1-1/3 NX: 270 2 g; P = NS) as well
as at the end of the study on day 14 (SHAM: 303 7 vs. UNX:
315 12 vs. 1-1/3 NX: 302 2 g; P = NS). Left kidney wet
weight was greater in the 1-1/3 NX and UNX groups compared
to the SHAM group (SHAM: 1.03 0.03 vs. UNX: 1.31 0.06
Fig. 2. Autoradiograph of Northern blot of
total RNA (20 p.g) extracted from 6 SHAM
operated rats, 5 with UNX, and 6 with 1-1/3
NX. A 32P random oligomer-pnmer labelled
clusterin (TRPM-2) cDNA probe was used for
hybridization. A photograph of the ethidium
bromide (ETBr) stained gel is shown below
the autoradiograph. Quantitation by
videodensitometry showed that the relative
clusterin mRNA level was sixfold higher in
the 1-1/3 NX as compared to the UNX and
SHAM groups. *p < 0.001.
vs. 1-1/3 NX: 1.28 0.02 g; P < 0.01). Serum creatinine at the
end of the study was significantly different among the three
groups with highest values, as expected, in the 1-1/3 NX group
(SHAM: 0.33 0.22 vs. UNX: 0.57 0.03 vs. 1-1/3 NX 0.82
0.05 mg/dl; P < 0.01).
Figure 2 contains an autoradiograph of the Northern blot of
RNA extracted from the left kidney of the three groups of rats
and hybridized with a clusterin cDNA probe. Quantitation by
computer assisted videodensitometry (Fig. 2) showed that the
relative clusterin mRNA level was significantly higher in the
1-1/3 NX group as compared to the SHAM and UNX groups
(SHAM: 207 19 vs. UNX: 208 11 vs. 1-1/3 NX: 1215 88
O.D. units; P < 0.001).
Time course of expression of clusterin following 1-1/3 NX
Figure 3 shows an autoradiograph of the Northern blot of
RNA extracted from the left kidney of SHAM and 1-1/3 NX rats
killed at different time points (3 hr, 24 hr, 3 days, 14 days, and
48 days), and hybridized with a clusterin cDNA probe. At each
time point, one SHAM operated rat and two subjected to 1-1/3
NX were included in the analysis. Three hours after surgery
there was no difference in clusterin mRNA between the SHAM
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Fig. 3. Autoradiograph of Northern blot of
total RNA (20 p.g) extracted from 5 SHAM
operated rats and JO with 1-1/3 NX at
different time points (3 hr, 24 hr, 3 days, 14
days, and 48 days) and hybridized with a
clusterin (TRPM-2) cDNA probe. At each
time point one SHAM and two 1 1/3 NX rats
were included. A photograph of the ethidium
bromide (ETBr) stained gel is shown below
the autoradiograph. Densitometry
measurements demonstrate that the increase
in clusterin mRNA following 1-1/3 NX
occurred between 3 and 24 hours and
remained elevated for at least 48 days.
and 1-1/3 NX groups. The increase in clusterin mRNA following
1-1/3 NX occurred between 3 and 24 hours and remained
consistently elevated for at least 48 days.
Time course of expression of clusterin following
uninephrectomy
In contrast to the marked increase in clusterin mRNA follow-
ing 1-1/3 NX, no increase in clusterin mRNA was seen in the
remaining left kidney following right nephrectomy. The ratio of
clusterin mRNA in the remaining left kidney compared to the
right kidney removed at time 0 were as follows: 3 hours 0.66, 24
hours 0.90, 3 days 0.34, and 14 days 0.75.
Intrarenal distribution clusterin mRNA in the remnant kidney
Figure 4 shows an autoradiograph of a Northern blot hybrid-
ized with a clusterin cDNA probe of total kidney RNA ex-
tracted from the half kidneys of four 1-1/3 NX rats. The scar
plus scar-adjacent tissue (S) displayed an eightfold increased
level of clusterin mRNA as compared to the non-scar tissue (N)
(S: 858 173 vs. N: 98 27; P < 0.005; Fig. 4).
Light microscopy
No histologic abnormalities were observed in the SHAM
operated kidney. Of note, no apoptosis was present. Two
weeks following 1-1/3 NX three distinct zones could be identi-
fied in the remnant kidney. These are illustrated in Figure 5a
which is the negative serum control for the immunoperoxidase
studies. The scar zone (S) was characterized by loss of the
normal renal architecture with replacement by fibrosis. A
distinct rim of tissue adjacent to the scar was easily identifiable.
Tubular atrophy was present in this scar-adjacent tissue (SA).
The tissue distant to the scar (N) showed no morphologic
abnormalities. Evidence for apoptosis was localized only to the
scar-adjacent tissue where apoptotic cells and apoptotic bodies
were present in a focal pattern in the tubular epithelium (Fig.
5b). Apoptotic cells were characterized by condensation of the
cytoplasm, compacted chromatin, and nuclear fragmentation.
Mitotic figures were present in some tubular cells, and in some
cases both apoptotic cells and cells undergoing mitosis were
present simultaneously in a tubule.
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Fig. 4. Autoradiograph of Northern blot of
total RNA (20 p.g) extracted from the S and N
halves of the kidneys of four 1-1/3 NX rats. A
32P random oligomer-primer labelled clusterin
(TRPM-2) cDNA probe was used for
hybridization. A photograph of the ethidium
bromide (ETBr) stained gel is shown below
the autoradiograph. Quantitation by
videodensitometry showed that the relative
clusterin mRNA level eightfold increased in
the S tissue as compared to the N tissue.
*P < 0.005.
Immunohisrochemistry
In SHAM operated rats, clusterin was detected by immuno-
peroxidase staining in occasional tubules, primarily in the
medulla (Fig. 5c). When a tubule was immunoreactive for
clusterin, all cells in that section of that tubule displayed
cytoplasmic staining for this protein. In the 1-1/3 NX remnant
kidney, clusterin staining of the tissue distant to the scar
showed a similar pattern to that seen in the SHAM operated
kidney, with only rare tubules being positive for clusterin. In
contrast, almost all tubules in the scar-adjacent tissue were
reactive for this protein, resulting in a band of clusterin immu-
noreactivity which clearly demarcated the scar tissue from the
normal kidney (Fig. 5d). As observed in the normal kidney,
when a tubule was positive, all cells in that section of that
tubule were immunoreactive. In some tubules the staining was
observed throughout the cytoplasm of the epithelial cells, with
intense staining of what appeared to be tubular remnants (Fig.
5e). In other tubules, staining was predominantly located at the
apical portion of the epithelial cells (Fig. 5f). Staining for
clusterin in the scar-adjacent tissue was seen in proximal and
distal tubules, collecting ducts, peritubular capillaries, but not
in glomeruli or interstitial cells. Clusterin was also found in
casts, some of which appeared to include sloughed tubular
epithelial cells.
Similar findings were seen with the immunofluorescence
studies. Renal tubules of the scar-adjacent area showed positive
staining for clusterin, which was not due to intrinsic autofiuo-
rescence, as this staining pattern was eliminated with the use of
a Iluosercein-blocking filter system. MAC was detected in an
interrupted-linear pattern along tubular basement membranes
*
c.j
z
E
C
4-,
U)
0
1000
800
600
400
200
0 I
•
I
S N
-
S S;t-...
—.-.———
-tS.
4.-.—
- —
-
,0-
1.
N
10
-I-li.
• 4.
S
a
S
r
I
. • • %
tI 9 .1
r'ra
SA
I
—-S• tel
-4
111,,jI,9.
t
w
944 Correa-R otter et a!: Clusterin distribution in renal ablation
Fig. 5. a. Negative control of immunoperoxidase stain of 1 1/3 NX kidney. An area of tubular atrophy in the scar-adjacent tissue (SA) separates
scar (S) from normal renal parenchyma (N) (non-immune rabbit serum, hematoxylin counterstain). b. Tubules in scar adjacent tissue display
apoptosis (arrows) (Hematoxylin and eosin). c. Immunoperoxidase staining of a kidney of a sham operated rat shows reactivity of all epithelial cells
seen in the cross section of one medullary tubule (rabbit anti-clusterin immunoperoxidase, hematoxylin counterstain), d. Most tubules in the
scar-adjacent tissue show reactivity for clusterin; resulting in a band of clusterin immunoreactivity which clearly demarcated the scar tissue from
the normal kidney, seen on the upper part of the figure. (Rabbit anti-clusterin immunoperoxidase, hematoxylin counterstain). e. Scar-adjacent renal
parenchyma of the 1-1/3 NX kidney; reactivity for clusterin is seen in tubular epithelial cells, tubular remnants (arrows) and endothelial cells of
peritubular capillaries (arrowheads). (Rabbit anti-clusterin immunoperoxidase, hematoxylin counterstain). 1. Scar-adjacent renal tissue of the 1-1/3
NX kidney; predominant apical cytoplasmic staining is seen in epithelial cells of tubule at lower left. (Rabbit anti-clusterin immunoperoxidase,
hematoxylin counterstain). Clusterin was also found in casts, some of which appeared to include sloughed tubular epithelial cells. Publication of
this figure in color was made possible by a grant from Marion Merrell Dow, Inc., Kansas City, Missouri, USA.
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Fig. 6. Immunofluorescencephotomicrographs of the pen-infarction zone of the 1-1/3 NXkidney. a. Deposition of the membrane attack complex
C5b-9 (MAC). b. Same field after correction for intrinsic autofluorescence of renal cells. As shown, most staining was due to autofluorescence with
minimal specific staining for MAC.
Table 1. Effect of 1-1/3 NX or 1/3 NX (limited infarction) on general
parameters
1-1/3 NX 1/3 NX (limited infarction)
Final body
weight g
MAP mm Hg
307
167
25
10
384
133
28
3'
Left kidney Right kidney
Kidney weight g
GFR mI/mm
1.29
0.80
0.11
0.39
0.65 019b
0.71 0.04
1.43 0.19
2.06
Data are presented as mean SEM. N = 7 for 1-1/3 NX and N = 4 for
1/3 NX.
P < 0.05 vs. 1-1/3 NX
"P < 0.01 vs. 1-1/3 NX
and in fine granules within segments of some glomeruli in
SHAM operated rats. In the regions remote from the infarcted
renal tissue, the pattern of distribution of MAC was similar to
that seen in SHAM rats. Within the infarcted tissue and the
pen-infarction zone, most staining was due to autofluorescence
with minimal specific MAC-staining (Fig. 6a and 6b). Thus, a
dissociation between clusterin and MAC was present.
Clusterin gene expression following limited infarction
At the end of this study (4 weeks), the mean body weight of
the 1/3 NX was significantly greater compared to that of the
1-1/3 NX group (1/3 NX: 384 28 vs. 1-1/3 NX: 307 25 g; P
< 0.05; Table 1). The wet weight of the left kidney was
significantly greater in the 1-1/3 NX group compared to that of
the 1/3 NX group (1-1/3 NX: 1.29 0.11 vs. 1/3 NX left kidney:
0,65 0.19g, P <0.01; Table 1). The weight of the right kidney
of the 1/3 NX group was similar to that expected for the right
kidney of an age and weight matched non-operated rat (1/3 NX
right kidney: 1.43 0.19 g).
GFR (determined by methoxy-3H inulin clearance) of the left
kidney of the 1/3 NX group was not significantly different from
that of the remnant kidney of the 1-1/3 NX group (1-1/3 NX:
0.80 0.39 vs. 1/3 NX: 0.71 0.04 mI/mm; p = NS). The right
kidney of the limited infarction group had a GFR of 2.06 0.22
mI/mm, thus the total GFR of the 1/3 NX group was 2.77 0.25
mI/mm. Mean arterial pressure was significantly higher in the
1-1/3 NX group as compared to the 1/3 NX group (1-1/3 NX: 167
10 vs. 1/3 NX: 133 3 mm Hg; P < 0.05; Table 1).
Autoradiographs hybridized with a clusterin cDNA probe of
RNA extracted from the left and right kidneys of the limited
infarction model demonstrated that the relative clusterin
mRNA level of the left kidney of the 1/3 NX group was sixfold
greater than that of the contralateral right kidney of the same
group (Fig. 7). Furthermore, the single remnant kidney (1-1/3
NX) expressed the most clusterin message. The densitometry
mean values obtained were significantly different among the
three groups (1-1/3 NX: 1537 107 vs. 1/3 NX right kidney: 128
25 vs. 1/3 NX left kidney: 789 112 O.D. units; P <0.005).
The presence of increased clusterin mRNA in the left kidney
of the 1/3 NX demonstrated that compensatory growth and/or
uremia were not necessary for increased expression of clusterin
mRNA, although the greater clusterin mRNA in the 1-1/3 NX
compared to the 1/3 NX left kidney suggests these or other
factors must be playing some additional role.
Gender differences in clusterin mRNA in the remnant kidney
Figure 8 displays an autoradiograph of a Northern blot of
RNA extracted from male and female SHAM and 1-1/3 NX rats.
The increased clusterin mRNA after 1-1/3 NX was confirmed in
male as well as in female rats. Female rats had a higher clusterin
mRNA than their male counterparts in the setting of both
SHAM operation and 1-1/3 NX (female SHAM 1287 vs. male
SHAM 209) (female 1-1/3 NX 5319 vs. male 1-1/3 NX 1723 O.D.
units; N = 2 each group).
Discussion
Clusterin mRNA was markedly increased after 1-1/3 NX as
compared to UNX and SHAM operation. This increased clus-
term mRNA occurred between 3 and 24 hours after the surgical
procedure and remained elevated for at least seven weeks.
When intrarenal distribution of clusterin mRNA and protein
was examined in the 1-1/3 NX kidney, the scar-adjacent tissue
(pen-infarct zone) displayed a significantly higher level of both
protein and message compared to the tissue 'distant from the
1/3 NX
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Fig. 7. Autoradiograph of Northern blot of
total RNA (20 jsg) extracted from the left and
right kidneys of the 1/3 NX group (N = 4) and
from the kidney of a 1-1/3 NX group (N = 7),
hybridized with a 32P random oligomer-primer
labelled clusterin (TRPM-2) cDNA probe. A
photograph of the ethidium bromide (ETBr)
stained gel is shown below the
autoradiograph. Quantitation by
videodensitometry showed that clusterin
mRNA level of the left kidney of the 1/3 NX
group was sixfold greater than that of the
right kidney of that same group (tP < 0.005).
The relative clusterin mRNA level of the 1-1/3
NX group was twice that of the left kidney of
the 1/3 NX group (p < 0.05).
scar." In the absence of compensatory growth and uremia (1/3
NX model), an increased level of clusterin mRNA was still
detectable in the partially infarcted left kidney. In contrast, no
increase in clusterin mRNA was detected following uninephrec-
tomy. Thus, a prolonged increase in clusterin mRNA and
protein occurred following renal ablation induced by partial
renal infarction.
The expression of clusterin and/or its mRNA has been
examined in several rat models of renal injury. After acute
unilateral ureteral obstruction renal clusterin mRNA was in-
creased at 30 minutes in blood vessels, and by 24 hours in
tubular epithelial cells [22, 27]. The increase in clusterin mRNA
peaked by 48 hours, and returned to near normal levels at day
7. Clusterin mRNA was also increased following nephrotoxic
injury induced by gentamicin, with greatest expression occur-
ring in the distal nephron 1301. In this model, increased levels of
the clusterin protein were detectable in urine and plasma.
Induction of clusterin mRNA also followed ischemialreperfu-
sion injury to the kidney with a positive correlation between
duration of ischemia and clusterin mRNA [28, 29]. Our exper-
iments demonstrate a marked increase in clusterin mRNA after
renal ablation performed by partial infarction, however, con-
trasting with the previous studies of acute injuries, this increase
was highly persistent, being present up to seven weeks after the
reduction of renal mass. The only other setting in which
prolonged expression of clusterin mRNA has been observed
was in the cyst wall epithelium of mice with autosomal-
recessive polycystic kidney disease, where increasing levels of
clusterin mRNA were present during the first six weeks of life
[31].
Although we initially viewed clusterin as being a possible
marker for progressive renal injury, the fact that uremia was not
necessary for an increase in clusterin mRNA to occur and the
localized expression of clusterin in the pen-infarct zone suggest
an alternative role for this protein, The area bordering the
scarred tissue has important anatomical and functional proper-
ties that could be directly related to the local induction of
clusterin at this level. The pen-infarct zone of the 1-1/3 NX
model shows ongoing morphologic evidence of ischemia, owing
to limited perfusion of this area by retrograde filling from the
capillaries of the contiguous non-infarcted tissue [39]. Renin
mRNA and protein are increased in the pen-infarct zone,
findings consistent with this being an area of ischemia [40]. The
presence of apoptosis in the tubular epithelial cells of the
pen-infarct area also suggests ischemia.
Apoptosis is the primary mode of cell death in renal ischemia,
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Fig. 8. Autoradiograph of Northern blot of
total RNA (20 g) extracted from male and
female SHAM and 1-1/3 NX rats, hybridized
with a 32P random oligomer-primer labelled
clusierin (TRPM-2) cDNA probe. A
photograph of the ethidium bromide (ETBr)
stained gel is shown below the
autoradiograph. Females had a higher
clusterin mRNA relative level than their male
counterparts in both settings.
and can constitute an ongoing tissue remodelling process lasting
for at least four weeks [41]. In contrast to cell necrosis, cell
death by apoptosis does not lead to an inflammatory response
and therefore, tissue architecture is maintained. Apoptosis is an
active process whereby nuclear and cytoplasmic material is
packaged by the cell into membrane bound particles called
apoptotic bodies which are taken up by neighboring cells or
macrophages where these bodies undergo lysosomal digestion
[421. This mode of cell deletion occurs during embryogenesis
[20], is part of normal tissue remodeling in adult organs [43, 44],
and occurs in a variety of pathologic states including prostate
regression [45], hepatic ischemia [46], adrenal cortical atrophy
following steroid administration [47], atrophy of pancreatic
exocrine tissue after duct obstruction [48], and in the kidney
following ureter obstruction [49] or renal artery stenosis [41].
Clusterin is increased in a number of these apoptotic states,
as well as in other conditions apparently unrelated to apoptosis.
For example, in the rat prostate, clusterin and its mRNA are
markedly elevated during prostate regression induced by cas-
tration, a model of hormone-initiated apoptosis [4, 6, 32]. This
process can be partially blocked by protein synthesis inhibitors,
providing evidence that synthesis of new proteins such as
clusterin are necessary for prostate regression [50]. Clusterin
mRNA is also highly induced in coordination with the onset of
cell death during the regression of interdigital tissue which
occurs during limb bud formation [20], during chemotherapeu-
tic regression of tumors [20], in scrapie-infected hamster brains
[51], in the hippocampus of patients with Alzheimer and Pick
diseases [511, and as discussed above, after ureter obstruction
and renal ischemia [22, 27—291. We speculate the increased
expression of clusterin in the pen-infarct zone of the 1-1/3 NX
kidney is related to the presence of ongoing apoptosis second-
ary to renal ischemia.
This association between apoptosis and clusterin has given
rise to the hypothesis that clusterin acts as a "trigger" to begin
the cascade of cellular processes which lead to apoptosis.
Alternatively, clusterin may not necessarily be acting as the
initiator of this process but may instead be one of several
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proteins needed for apoptosis to be carried out in an orderly
fashion. One potential function for clusterin may be in lipid
transport between dying apoptotic cells and their neighbors.
Clusterin co-elutes in human plasma with apolipoprotein A-I
(apoA-I), a major structural protein of high density lipoproteins
(HDL) [23]. This clusterin-apoA-I HDL complex, which has
also been named NAI/NA2 [17] and apolipoprotein J [18, 19],
has a high protein content (78%), is rich in free cholesterol, and
migrates as a slow HDL on isotachophoresis. Based on the
proposed functions of slow migrating HDL fractions, Jenne et
al inferred that clusterin may be involved in lipid transport
between cells [23]. These investigators went on to postulate that
the inducibility of clusterin during the process of cell death
suggested a role for clusterin in lipid scavenging and recycling
[23]. This explanation is consistent with the large amounts of
membrane lipid which must be handled by neighboring cells
during the process of apoptosis. In support for a role of
clusterin in lipid scavenging and not the initiation of apoptosis is
the finding of clusterin in all cells of a positive tubule whereas
apoptotic cells are found more focally.
Human clusterin was originally isolated from the glomerular
immune deposits of a patient with membrane glomerulonephri-
tis [7]. Clusterin is a component of the fluid phase membrane
attack complex SC5b-9 [7, 11, 12]. In vitro, clusterin inhibits
complement mediated cytolysis by binding to the nascent C5b-7
complex, a property it shares with S protein/vitronectin, an-
other SC5b-9 associated protein [12, 24, 52]. In human renal
biopsies immunofluorescence studies have demonstrated clus-
term to be present in association with components of SC5b-9 in
both specific immune glomerular deposits as well as in the
non-specific deposits associated with diverse forms of renal
injury [25]. Similarly in the rat, clusterin was found in associa-
tion with CSb-9 in a complement-mediated model of renal
injury, that of Heymann nephritis [26]. When systemic comple-
ment depletion was induced in this model, and the formation of
the membrane attack complex was prevented, clusterin was no
longer deposited. The presence of clusterin in association with
the membrane attack complex and its ability to inhibit comple-
ment mediated cytolysis, suggests clusterin may play a role in
the regulation of complement-induced renal injury. The absence
of co-localization of clusterin with C5b-9 in our study does not
totally exclude a potential regulatory role for clusterin on the
cytolytic activity of the membrane attack complex, but speaks
against it. Further evidence against an interaction between
complement and clusterin in this model comes from studies of
complement deficient mice. Following subtotal nephrectomy
clusterin mRNA was elevated in both complement sufficient
and complement deficient mice subjected to subtotal nephrec-
tomy 153]. The dissociation between clusterin and CSb-9 in our
study could be related to an efficient protective action of
clusterin in actively inhibiting cytolytic activity of the mem-
brane attack complex of complement and consequently the
formation of deposits.
Several other points regarding the localization of clusterin in
our study deserve emphasis. When clusterin was found in either
the SHAM operated or 1-1/3 nephrectomy kidney, all of the
cells of a section of the tubule expressed clusterin. This finding
suggests the expression of clusterin may be regulated on a
single nephron level, perhaps by a change in filtration, the
filtration of specific substances, or alterations in tubule trans-
port by other means such as obstruction. If the expression of
clusterin is related to apoptosis, the focal nature of its localiza-
tion in the SHAM kidney could be related to normal tissue
remodeling processes and/or nephron loss which are part of
aging [541. The finding of clusterin in the endothelial cells of
peritubular capillaries in the scar-adjacent tissue is consistent
with a more generalized response to a clusterin-inducible stim-
ulus beyond what occurs in renal tubular epithelial cells.
Finally, the presence of clusterin in sloughed renal tubular
epithelial cells and renal casts following 1-1/3 NX, suggests
urinary clusterin could be a potentially useful clinical marker
for renal epithelial cell injury. In this regard, preliminary data
has demonstrated clusterin excretion is increased following
administration of gentamicin [30].
The differing levels of clusterin gene expression in male and
female rats also tends to support a protective role for clusterin.
Expression of clusterin mRNA was higher in female compared
to male rats following both sham operation and 1-1/3 NX. This
lower expression in male rats is consistent with the testoster-
one-induced expression that has been previously described [4,
6, 32]. Since female rats are less susceptible to renal injury
following renal ablation [55], we speculate that increased clus-
term expression could be more effectively limiting renal injury
in female rats after partial renal ablation.
In conclusion, a highly and persistently increased expression
of clusterin was found following partial renal ablation and was
related to the presence of an area of ongoing renal ischemia
adjacent to the renal scar. This increased expression may be
playing a role in the ischemia-related apoptosis present in the
scar-adjacent tissue.
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